Industry News
Fetal Exposure To Carcinogens Leading To Cancer Depends On Dose, Timing
Dec 20, 2011
The cancer-causing potential of fetal exposure to carcinogens can vary substantially, a recent study suggests, causing different types of problems much later in life depending on the stage of pregnancy when the fetus is exposed. The research sheds further light on the way in which toxic damage early in life can later manifest themselves as cancer, due to "epigenetic" changes in cells... Read More
Phase 2 Trial Finds Spread Of Nasopharyngeal Carcinoma Is Reduced By Bevacizumab
Dec 20, 2011
The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side effects... Read More
Advantages And Motivations Uncertain Behind Use Of Brachytherapy For Breast Cancer Radiotherapy
Dec 20, 2011
Accelerated partial breast irradiation using brachytherapy (APBIb) for the treatment of breast cancer has been rapidly increasing over the last several years in the U.S. as an alternative to standard whole-breast irradiation (WBI), according to a study published in the Journal of the National Cancer Institute... Read More
No Brakes On Breast Cancer Cells
Dec 20, 2011
MicroRNAs or miRNAs are tiny RNA molecules that have only about 20 nucleotides and do not code for proteins. They regulate many important processes in cells by binding to target messenger RNAs - the instructions for protein production - thus blocking production of the respective protein. In cancer, the production of some miRNAs is often reduced or amplified... Read More
Potential To Double The Efficacy Of Radiation Therapy
Dec 20, 2011
Scientists may have a way to double the efficacy and reduce the side effects of radiation therapy. Georgia Health Sciences University scientists have devised a way to reduce lung cancer cells' ability to repair the lethal double-strand DNA breaks caused by radiation therapy. "Radiation is a great therapy - the problem is the side effects," said Dr. William S... Read More
Fetal Exposure To Carcinogens Leading To Cancer Depends On Dose, Timing
Dec 20, 2011
The cancer-causing potential of fetal exposure to carcinogens can vary substantially, a recent study suggests, causing different types of problems much later in life depending on the stage of pregnancy when the fetus is exposed. The research sheds further light on the way in which toxic damage early in life can later manifest themselves as cancer, due to "epigenetic" changes in cells... Read More
Mobile MIM Receives Second FDA 510(k) Clearance, Adds X-Ray And Radiation Oncology
Dec 19, 2011
MIM Software Inc., a leading global provider of medical imaging software, announced today that Mobile MIM™ has received its second FDA 510(k) clearance for the release of its new version, Mobile MIM 3.0. Mobile MIM is now cleared for diagnostic X-ray and ultrasound viewing, as well as radiation treatment plan review and approval. Mobile MIM 3... Read More
Smoking Raises Risk Of Squamous Cell Carcinoma Of The Skin In Women
Dec 19, 2011
Regular female smokers have a threefold higher risk of developing squamous cell carcinoma of the skin, researchers from Moffitt Cancer Center reported in Cancer Causes and Control. The authors said they found a slight increase in risk among regular male smokers, but a statistically insignificant one. Dana E... Read More
The International Association For The Study Of Lung Cancer Sets Up Committee To Move CT Lung Cancer Strategic Screening Forward
Dec 19, 2011
The International Association for the Study of Lung Cancer (IASLC) has taken a proactive role in advancing discussions with the international lung cancer community on how we should take lung cancer screening forward... Read More
Researchers Discover Hereditary Predisposition Of Melanoma Of The Eye
Dec 19, 2011
Ohio State University researchers have discovered a hereditary cancer syndrome that predisposes certain people to a melanoma of the eye, along with lung cancer, brain cancer and possibly other types of cancer. The hereditary cancer syndrome is caused by an inherited mutation in a gene called BAP1, researchers say... Read More
Previous Page Next Page